These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26052724)

  • 1. Chitosan nanoparticles as adenosine carriers.
    Kazemzadeh-Narbat M; Reid M; Brooks MS; Ghanem A
    J Microencapsul; 2015; 32(5):460-6. PubMed ID: 26052724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine.
    Mishra D; Jain N; Rajoriya V; Jain AK
    J Pharm Pharmacol; 2014 Aug; 66(8):1082-93. PubMed ID: 24641311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release.
    Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W
    Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.
    Liu P; Zhao X
    Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
    Pawar H; Douroumis D; Boateng JS
    Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS; Farid RM; ElGamal SS
    Drug Dev Ind Pharm; 2015; 41(12):2055-68. PubMed ID: 26133084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers.
    Dong Y; Ng WK; Shen S; Kim S; Tan RB
    Carbohydr Polym; 2013 May; 94(2):940-5. PubMed ID: 23544653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxymethyl chitosan-soy protein complex nanoparticles for the encapsulation and controlled release of vitamin D₃.
    Teng Z; Luo Y; Wang Q
    Food Chem; 2013 Nov; 141(1):524-32. PubMed ID: 23768389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release.
    Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H
    Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization.
    Ayumi NS; Sahudin S; Hussain Z; Hussain M; Samah NHA
    Drug Deliv Transl Res; 2019 Apr; 9(2):482-496. PubMed ID: 29569027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of novel composite alginate chitosan-carrageenan nanoparticles for encapsulation of BSA as a model drug delivery system.
    Cheng L; Bulmer C; Margaritis A
    Curr Drug Deliv; 2015; 12(3):351-7. PubMed ID: 26054536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of zein/chitosan complex for encapsulation of α-tocopherol, and its in vitro controlled release study.
    Luo Y; Zhang B; Whent M; Yu LL; Wang Q
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):145-52. PubMed ID: 21440424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
    Zameer S; Ali J; Vohora D; Najmi AK; Akhtar M
    J Drug Target; 2021 Feb; 29(2):199-216. PubMed ID: 32876502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib loaded chitosan nanoparticles formulation and its evaluation.
    Joseph JJ; Sangeetha D; Gomathi T
    Int J Biol Macromol; 2016 Jan; 82():952-8. PubMed ID: 26522243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release of ATP encapsulated in chitosan oligosaccharide nanoparticles.
    Du YZ; Ying XY; Wang L; Zhai Y; Yuan H; Yu RS; Hu FQ
    Int J Pharm; 2010 Jun; 392(1-2):164-9. PubMed ID: 20362652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.